Fingerprint
Dive into the research topics of 'First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically